NCT02669264 2021-05-24Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL)ADC Therapeutics S.A.Phase 1 Terminated35 enrolled 31 charts